Ad
related to: PTCT
Search results
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 day agoPTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely...
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
Zacks via Yahoo Finance· 1 month agoPTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to...
Here's Why PTC Therapeutics (PTCT) is Poised for a Turnaround After Losing 23.4% in 4 Weeks
Zacks via Yahoo Finance· 1 year agoPTC Therapeutics (PTCT) is technically in oversold territory now, so the heavy selling pressure...
PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024
Zacks via Yahoo Finance· 7 months agoPTC Therapeutics (PTCT) will reduce its workforce in accordance with its strategic prioritization...
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD Drug
Zacks via Yahoo Finance· 7 months agoPTC Therapeutics (PTCT) plunges on negative opinion from the Committee for Medicinal Products for...
PTC Therapeutics Inc (PTCT) Reports Q3 2023 Earnings: Revenue of $197 Million
GuruFocus.com via Yahoo Finance· 6 months agoPTC Therapeutics Inc (NASDAQ:PTCT) reported Q3 2023 total revenues of $197 million. The company's...
FMR LLC Trims Stake in PTC Therapeutics Inc
GuruFocus.com via Yahoo Finance· 5 months agoOverview of FMR LLC (Trades, Portfolio)'s Recent Trade FMR LLC (Trades, Portfolio), a prominent investment firm, has recently adjusted its investment in...
PTC Therapeutics (PTCT) Lost 16% in Q2
Insider Monkey via Yahoo Finance· 7 months agoTimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A...
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPTC Therapeutics (PTCT) delivered earnings and revenue surprises of -14.84% and 2.41%, respectively,...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 11 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
